Tafasitamab 用于治疗弥漫性大 B 细胞淋巴瘤患者。
关键词: Anti CD-19 agent DLBCL Tafasitamab relapsed-refractory disease; monoclonal antibodies
Mesh : Humans Lymphoma, Large B-Cell, Diffuse / drug therapy etiology Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents / therapeutic use Lymphoma, Non-Hodgkin Antineoplastic Combined Chemotherapy Protocols / adverse effects
来 源:
DOI:10.1080/21645515.2024.2309701
PDF(Pubmed)